Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry
暂无分享，去创建一个
R. Cimaz | I. Pontikaki | V. Gerloni | E. Miserocchi | F. Zulian | C. Bracaglia | G. Martini | F. Vittadello | F. Corona | G. Simonini | F. Falcini | F. Parentin | S. Viola | L. Breda | M. E. Zannin | M. Paroli | F. Torre | R. D. Marco | C. Birolo | A. Shardlow